Intermittent Versus Continuous Tarceva Study

NCT01243047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Chemotherapy

Sponsor

Chinese University of Hong Kong